AlphaQuest LLC Purchases 83,213 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

AlphaQuest LLC boosted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 1,989.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 87,395 shares of the company's stock after acquiring an additional 83,213 shares during the period. AlphaQuest LLC owned 0.14% of Health Catalyst worth $618,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quest Partners LLC bought a new stake in shares of Health Catalyst during the third quarter valued at approximately $34,000. Quadrature Capital Ltd bought a new stake in shares of Health Catalyst during the third quarter valued at approximately $84,000. Stoneridge Investment Partners LLC bought a new stake in shares of Health Catalyst during the fourth quarter valued at approximately $77,000. Intech Investment Management LLC bought a new stake in shares of Health Catalyst during the third quarter valued at approximately $145,000. Finally, Creative Planning raised its position in shares of Health Catalyst by 13.2% during the third quarter. Creative Planning now owns 21,348 shares of the company's stock valued at $174,000 after buying an additional 2,486 shares during the last quarter. Institutional investors own 85.00% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on HCAT shares. Canaccord Genuity Group reduced their price objective on shares of Health Catalyst from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Tuesday, January 21st. Royal Bank of Canada reduced their price target on shares of Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating on the stock in a research report on Thursday, February 27th. Piper Sandler reduced their price target on shares of Health Catalyst from $12.00 to $8.00 and set an "overweight" rating on the stock in a research report on Tuesday, February 11th. Citigroup reduced their price target on shares of Health Catalyst from $10.50 to $10.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Finally, Wells Fargo & Company reduced their price target on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $9.27.

Remove Ads

Insiders Place Their Bets

In other news, COO Daniel Lesueur sold 16,902 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the sale, the chief operating officer now directly owns 216,250 shares of the company's stock, valued at approximately $977,450. The trade was a 7.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Linda Llewelyn sold 6,442 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $7.88, for a total transaction of $50,762.96. Following the sale, the insider now directly owns 98,702 shares of the company's stock, valued at $777,771.76. This represents a 6.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 71,972 shares of company stock valued at $412,930 over the last three months. 2.50% of the stock is owned by company insiders.

Health Catalyst Stock Up 5.0 %

NASDAQ HCAT opened at $4.17 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average of $5.62 and a two-hundred day moving average of $7.11. The firm has a market capitalization of $292.78 million, a price-to-earnings ratio of -3.09 and a beta of 1.41. Health Catalyst, Inc. has a 52 week low of $3.76 and a 52 week high of $9.24.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Want to see what other hedge funds are holding HCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Catalyst, Inc. (NASDAQ:HCAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.